Neuroprotective Natural Products for the Treatment of Parkinson's Disease by Targeting the Autophagy-Lysosome Pathway: A Systematic Review

被引:41
|
作者
Wang, Zi-Ying [1 ,2 ]
Liu, Jing-Yi [1 ,2 ]
Yang, Chuan-Bin [1 ,2 ]
Malampati, Sandeep [1 ,2 ]
Huang, Ying-Yu [1 ,2 ]
Li, Mei-Xiang [1 ,2 ]
Li, Min [1 ]
Song, Ju-Xian [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Baptist Univ, Mr & Mrs Ko Chi Ming Ctr Parkinsons Dis Res, Kowloon, Hong Kong, Peoples R China
关键词
Parkinson's disease; autophagy; neuroprotection; natural products; UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; RAT MODEL; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; CELLULAR-MODELS; DOWN-REGULATION; SH-SY5Y CELLS; MTOR; DEGRADATION;
D O I
10.1002/ptr.5834
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The autophagy-lysosome pathway (ALP) is a primary means by which damaged organelles and long-lived proteins are removed from cells and their components recycled. Impairment of the ALP has been found to be linked to the pathogenesis of Parkinson's disease (PD), a chronic neurodegenerative disorder characterized by the accumulation of protein aggregates and loss of dopaminergic neurons in the midbrain. In recent years, some active compounds derived from plants have been found to regulate the ALP and to exert neuroprotective effects in experimental models of PD, raising the possibility that autophagy enhancement may be an effective therapeutic strategy in PD treatment. In this review, we summarize recent findings of natural products that enhance ALP and thereby protect against PD. Research articles were retrieved from PubMed using relevant keywords in combination. Papers related to the topic were identified, and then the reliability of the experiments was assessed in terms of methodology. The results suggest that targeting the ALP with natural products is a promising strategy for PD treatment. However, risk of bias exists in some studies due to the defective methodology. Rigorous experimental design following the guidelines of autophagy assays, molecular target identification and in vivo efficacy evaluation is critical for the development of ALP enhancers for PD treatment in future studies. Copyright (C) 2017 John Wiley & Sons, Ltd.
引用
收藏
页码:1119 / 1127
页数:9
相关论文
共 50 条
  • [31] Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB
    He, Ruizhi
    Shi, Xiuhui
    Zhou, Min
    Zhao, Yan
    Pan, Shutao
    Zhao, Chunle
    Guo, Xingjun
    Wang, Min
    Li, Xu
    Qin, Renyi
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 356 : 159 - 171
  • [32] Targeting the JAK/STAT pathway in the treatment of Parkinson's disease
    Qin, Hongwei
    Buckley, Jessica
    Liu, Yudong
    Holdbrooks, Andrew
    Benveniste, Etty
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [33] Selected Natural Products in Neuroprotective Strategies for Alzheimer's Disease-A Non-Systematic Review
    Wojtunik-Kulesza, Karolina
    Oniszczuk, Tomasz
    Moldoch, Jaroslaw
    Kowalska, Iwona
    Szponar, Jaroslaw
    Oniszczuk, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [34] UNC93B1 attenuates the cGAS-STING signaling pathway by targeting STING for autophagy-lysosome degradation
    Zhu, Huifang
    Zhang, Rongzhao
    Yi, Li
    Tang, Yan-Dong
    Zheng, Chunfu
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (09) : 4490 - 4501
  • [35] Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway
    Bao, Lanxin
    Ye, Jing
    Liu, Nannan
    Shao, Yubao
    Li, Wenhao
    Fan, Xuefei
    Zhao, Dahai
    Wang, Hongzhi
    Chen, Xiaoyu
    MOLECULES, 2022, 27 (23):
  • [36] Neuroprotective Natural Products for Alzheimer's Disease
    Chen, Xin
    Drew, Joshua
    Berney, Wren
    Lei, Wei
    CELLS, 2021, 10 (06)
  • [37] Treatment of Dysphagia in Parkinson's Disease: A Systematic Review
    Lopez-Liria, Remedios
    Parra-Egeda, Jennifer
    Vega-Ramirez, Francisco A.
    Manuel Aguilar-Parra, Jose
    Trigueros-Ramos, Ruben
    Jose Morales-Gazquez, Maria
    Rocamora-Perez, Patricia
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (11) : 1 - 13
  • [38] Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease
    He, Ting
    Lin, Xiaoyan
    Su, Anping
    Zhang, Yujie
    Xing, Zhichao
    Mi, Li
    Wei, Tao
    Li, Zhihui
    Wu, Wenshuang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [39] Autophagy related genes polymorphisms in Parkinson's Disease; A systematic review of literature
    Yousefi, Parastoo
    Ghadirian, Shahrzad
    Mobedi, Maryam
    Jafarzadeh, Mehrzad
    Alirezaei, Adib
    Gholami, Ali
    Tabibzadeh, Alireza
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2025, 12
  • [40] Parkinson's disease-linked LDL Receptor Related Protein 10 (LRP10) is implicated in regulation of the secretory and autophagy-lysosome pathways
    Mascaro, A. Carreras
    Grochowska, M. M.
    Boumeester, V.
    Bonifati, V.
    Mandemakers, W.
    MOVEMENT DISORDERS, 2021, 36 : S331 - S331